DA-5230-R

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-5230-R, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R [Phase 1]